Zobrazeno 1 - 6
of 6
pro vyhledávání: '"I. Shchendrigin"'
Publikováno v:
European Journal of Preventive Cardiology. 28
Funding Acknowledgements Type of funding sources: Public grant(s) – National budget only. Main funding source(s): State Task Introduction. Assessment of vascular age (VA), based on the determination of the arterial stiffness (AS), is attracting mor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e66f6088f52c92586920c8db8454fada
https://doi.org/10.1093/eurjpc/zwab061.147
https://doi.org/10.1093/eurjpc/zwab061.147
Autor:
E. Gubar, T. Korotaeva, Y. Korsakova, E. Loginova, L. Vorobyova, S. Glukhova, E. Nasonov, V. Sorotskaya, I. Kushnir, I. Shchendrigin, I. Umnova, P. Shesternya
Publikováno v:
Annals of the Rheumatic Diseases. 81:1592.2-1593
BackgroundThe latest data show that psoriatic arthritis (PsA) patients (pts) with asymmetrical sacroiliitis (SI) have clinical and genetic features which are considered typical for PsA (1).ObjectivesTo analyze comparative clinical characteristics of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e1f9eb3c31c3e78466ff7cae0bef4e05
https://doi.org/10.1136/annrheumdis-2022-eular.1589
https://doi.org/10.1136/annrheumdis-2022-eular.1589
Autor:
E. Loginova, T. Korotaeva, E. Gubar, Y. Korsakova, S. Glukhova, E. Nasonov, V. Sorotskaya, I. Patrikeeva, P. Shesternya, I. Shchendrigin
Publikováno v:
Annals of the Rheumatic Diseases. 81:867-867
BackgroundPsoriatic arthritis (PsA) is a disease with multidomain clinical presentation such as arthritis, enthesitis, dactylitis, spondylitis and psoriasis (PsO). [1]. Enthesitis is a key clinical feature of PsA with significant impact on function,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0d572071d40a8e6c2f304e5183680e44
https://doi.org/10.1136/annrheumdis-2022-eular.2554
https://doi.org/10.1136/annrheumdis-2022-eular.2554
Autor:
V. Sorotskaya, Nasonov El, N. Kuznetsova, Tatiana Korotaeva, Irina Umnova, M. Chamurlieva, Y. Korsakova, Elena Loginova, I. Shchendrigin, E. Gubar, I. Patrikeeva, Svetlana Glukhova
Publikováno v:
Annals of the Rheumatic Diseases. 80:1325.2-1326
Background:Psoriatic arthritis (PsA) is heterogeneous in its clinical presentation and disease course, but many patients (pts) develop a destructive form of arthritis. Psoriasis (PsO) precedes arthritis by an average of 7 years. [1]. Theory of transi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9541e76d61637ce5b00a7a833b3255d8
https://doi.org/10.1136/annrheumdis-2021-eular.2796
https://doi.org/10.1136/annrheumdis-2021-eular.2796
Autor:
R. Samigullina, N. Kiryukhina, T. Salnikova, T. Rasevich, Nasonov El, E. Kalinina, I. Semizarova, I. Bashkova, D. Kretchikova, D. Bobrikova, I. Vinogradova, V. Sorotskaya, E. Koltsova, A. Dyo, I. Shchendrigin, O. Semagina, A. Dadalova, M. Semchenkova, D. Murtazalieva, Alexander Lila, V. Mazurov, D. Chakieva, A. Davydova, I. Shafieva, A. Baranov, N. Lapkina, I. M. Marusenko, I. Kushnir, A. Karateev
Publikováno v:
Annals of the Rheumatic Diseases. 80:1095.3-1096
Background:JAK inhibitors block intracellular signaling pathways responsible for the synthesis of cytokines and mediators involved in the development of chronic pain and central sensitization (CS). This determines a very rapid clinical response to JA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::77f9af1890928d01dac7b7df61f2fca8
https://doi.org/10.1136/annrheumdis-2021-eular.2902
https://doi.org/10.1136/annrheumdis-2021-eular.2902
Publikováno v:
Arthritis & Rheumatology; Sep2021 Supplemene S1, Vol. 73, p1-4204, 4204p